Side-by-side comparison of AI visibility scores, market position, and capabilities
Mumbai India YC secured lending platform for instant loans against mutual funds and stocks in 5 minutes; ₹9.2Cr seed Mar 2025 (YC/Pioneer/Team Ignite) at 10.5% flat rate democratizing securities-backed lending for India's 100M+ retail investors.
Yenmo is a Mumbai, India-based secured consumer lending platform — backed by Y Combinator with $500,000 from Y Combinator in March 2024 and ₹9.2 crore ($1.1 million) in seed funding in March 2025 from Y Combinator, Pioneer Fund, and Team Ignite Ventures — providing Indian retail investors and consumers with instant loans against mutual funds and stock portfolios (securities-backed lending) at a 10.5% flat interest rate with processing in under 5 minutes, democratizing access to financial products previously accessible only to high-net-worth individuals through traditional broker margin facilities. Founded in 2023 by Ashutosh Purohit, Yenmo generated ₹97.3 lakh ($116,000) in annual revenue in FY2024.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.